These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1352874)

  • 1. Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices.
    Stull RA; Taylor LA; Szoka FC
    Nucleic Acids Res; 1992 Jul; 20(13):3501-8. PubMed ID: 1352874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides: from design to therapeutic application.
    Chan JH; Lim S; Wong WS
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of antisense oligonucleotides on the basis of genomic frequency of the target sequence.
    Han J; Zhu Z; Hsu C; Finley WH
    Antisense Res Dev; 1994; 4(1):53-65. PubMed ID: 8061516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences.
    Yoshida T; Naito Y; Sasaki K; Uchida E; Sato Y; Naito M; Kawanishi T; Obika S; Inoue T
    Genes Cells; 2018 Jun; 23(6):448-455. PubMed ID: 29667281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
    Liang XH; Sun H; Nichols JG; Crooke ST
    Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
    Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
    J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
    Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a specific intracellular localization of an antisense oligonucleotide in k562 cells.
    Vasconcelos MH; Maia LF; Sousa C; Beleza SS; GuimarĂ£es JE
    J Pharmacol Sci; 2005 Sep; 99(1):105-8. PubMed ID: 16141637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.
    Zhang HY; Mao J; Zhou D; Xu Y; Thonberg H; Liang Z; Wahlestedt C
    Nucleic Acids Res; 2003 Jul; 31(14):e72. PubMed ID: 12853649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.
    Laptev AV; Lu Z; Colige A; Prockop DJ
    Biochemistry; 1994 Sep; 33(36):11033-9. PubMed ID: 8086420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs.
    Liang XH; Nichols JG; Sun H; Crooke ST
    Nucleic Acids Res; 2018 Jan; 46(1):293-313. PubMed ID: 29165591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of an RNA Quadruplex-Duplex Hybrid in Living Cells between mRNA of the Epidermal Growth Factor Receptor (EGFR) and a G-Rich Antisense Oligoribonucleotide.
    Gudanis D; Kaniowski D; Kulik K; Baranowski D; Gdaniec Z; Nawrot B
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
    Vickers TA; Crooke ST
    Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages.
    Liang XH; Sun H; Shen W; Crooke ST
    Nucleic Acids Res; 2015 Mar; 43(5):2927-45. PubMed ID: 25712094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of antisense oligonucleotide binding affinity to a structured RNA target.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biotechnol Bioeng; 1999 Oct; 65(1):1-9. PubMed ID: 10440665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.
    Kretschmer-Kazemi Far R; Sczakiel G
    Nucleic Acids Res; 2003 Aug; 31(15):4417-24. PubMed ID: 12888501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of off-target effects of gapmer antisense oligonucleotides using human cells.
    Yoshida T; Naito Y; Yasuhara H; Sasaki K; Kawaji H; Kawai J; Naito M; Okuda H; Obika S; Inoue T
    Genes Cells; 2019 Dec; 24(12):827-835. PubMed ID: 31637814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.